Advanced Malignant Neoplasm: Clinical Trials

3 trials for Advanced Malignant Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 3
Phase 22Active not recruiting 2

Follow Advanced Malignant Neoplasm: new trials by email Literature Review of Advanced Malignant Neoplasm trials Research Report on Advanced Malignant Neoplasm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
Laboratory Biomarker Analysis, Methylphenidate, Physical Activity - Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm
Phase 3Active not recruitingM.D. Anderson Cancer Center2122018-08-022026-10-06
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
Chlorpromazine, Haloperidol, Quality-of-Life Assessment - Advanced Malignant Neoplasm, Delirium
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center702017-06-052026-09-14
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
Dexamethasone, Exercise Intervention, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Fatigue
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center902015-08-132026-09-22

Narrower conditions

Neoplasm Metastasis (3)  ·  Recurrence (3)  ·  Delirium (1)  ·  Fatigue (1)  ·  Neoplasms (1)

Broader conditions

Disease Attributes (3)  ·  Neoplastic Processes (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neoplasms (2)  ·  Signs and Symptoms (2)  ·  Confusion (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)

Interventions

Calcium Dobesilate (1)  ·  Chlorpromazine (1)  ·  Dexamethasone (1)  ·  Exercise (1)  ·  Haloperidol (1)  ·  Methylphenidate (1)  ·  auricularum (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)

Sponsors

M.D. Anderson Cancer Center (3)

Countries

United States (3)

Top investigators

Sriram Yennu (2)  ·  David Hui (1)

Results publications

PMID 32479786, PMID 34965510

NIH funding

R21NR016736 (1)